Recent Blood Clot News from ScienceDaily:

• Milvexian an effective and safe oral pill for prevention of venous blood clots, says study
• Anticoagulant has beneficial side-effects for COVID-19 patients, study finds
• Genes may affect the level of harmful bacterial toxins in the bloodstream
• Personalized clotting profiles may help in next generation of precision heart disease treatments
• Off-target immune response could predict COVID-19 severity
• Platelets key to blood vessel damage in COVID-19 patients
• Genetic test better than blood test for cardiovascular diseases
• Blood clotting may be the root cause of Long COVID syndrome, research shows
• Blood clots in people with severe COVID-19 may be related to abnormal antibody response
• Abelacimab effective blood clot treatment, study suggests
• New theory suggests blood immune and clotting components could contribute to psychosis
• Engineers find imaging technique could become treatment for deep vein thrombosis
• Study shows benefits of early anticlotting therapy in moderate COVID-19
• Why some COVID-19 patients develop life-threatening clots
• A breakthrough in the physics of blood clotting
• Mini bone marrow model predicts response to blood disorder treatment
• Potential causality between blood clot factors and migraine with aura
• COVID-19 vaccination: Thrombosis can be prevented by prompt treatment, researchers report
• Researchers report first instance of COVID-19 triggering recurrent blood clots in arms
• Scientists’ discovery of blood clotting mechanism could lead to new antithrombotic drugs
• Two blood thinners at once: More risk with the same reward
• New tech aims to tackle ‘disseminated intravascular coagulation’ blood disorder
• Elevated clotting factor V levels linked to worse outcomes in severe COVID-19 infections
• Possible blood-clotting mechanism in COVID-19 found
• What is cerebral venous thrombosis? Study finds blood clot condition on the rise
• COVID-19: The virus and the vasculature
• Blood-thinner with no bleeding side-effects is here
• Transferrin identified as potential contributor to COVID-19 severity
• Study suggests increased risks for COVID-19 patients who smoke, vape
• Dangerous blood clots form in leg arteries of COVID-19 patients
• New antiplatelet drug shows promise for treating heart attack
• COVID-19 causes ‘hyperactivity’ in blood-clotting cells
• Novel function of platelets in tumor blood vessels found
• New way to detect blood clots
• Pulmonary embolism and COVID-19
• Blood clotting abnormalities reveal COVID-19 patients at risk for thrombotic events
• New tool helps distinguish the cause of blood clots
• How spaceflight affects risk of blood clots in female astronauts
• Blood clotting a significant cause of death in patients with COVID-19
• Higher thrombus risk in men with obesity in adolescence
• New research highlights blood clot dangers of COVID-19
• Muscle protein abundant in the heart plays key role in blood clotting during heart attack
• Ultimate Telemedicine: Expert helps treat astronaut’s blood clot during NASA mission
• New spray gel could help take the bite out of frostbite
• ‘Smart’ surfaces to help blood-vessel grafts knit better, more safely
• Treating pulmonary embolism: How safe and effective are new devices?
• Cellular senescence is associated with age-related blood clots
• Lab-on-a-chip drives search for new drugs to prevent blood clots
• Targeting inflammation to better understand dangerous blood clots
• Presence of oral bacteria in cerebral emboli of stroke patients